ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
4,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
4,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4,3,Headache,Headaches NEC,Headaches,Nerv,N
4,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4,6,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
6,1,Bile acids increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
6,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
9,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
10,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
11,2,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
11,3,Hepatitis D RNA positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
12,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
12,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
13,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
14,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
15,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
16,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
